Medical Device Nonvisual Accessibility Act of 2023

HR 1328, the Medical Device Nonvisual Accessibility Act of 2023, requires certain home-use medical devices (like blood pressure monitors and sleep apnea machines) to include nonvisual accessibility features - such as voice commands or audio feedback - by 2025. It directly affects blind or low-vision users who rely on these devices for independent, safe, and private care at home. The bill mandates that devices classified as Class II or III (and cleared via FDA processes) must meet accessibility standards ensuring equal usability for blind or low-vision individuals, with limited waivers allowed for manufacturers facing undue hardship. The FDA will develop and enforce these standards within two years, consulting with accessibility experts and blind users.